MedTrace Logo

Research Collaboration for a Precision Oncology Program (POP)

NCT06680726 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-08

No results posted yet for this study

Summary

The Precision Oncology Program (POP) research collaboration aims to help generate information about the individual tumour biology for patients with advanced malignancies, using innovative biotechnologies and patient profile comparison ("matching") against specific databases (Real-world data, RWD) and to inform about potential benefit, or lack of benefit, from a given treatment.

Conditions

Interventions

OTHER

Matching with RWD

A set of clinical and genetic data are matched to generate a RWD cohort for comparison.

OTHER

Imaging Mass Cytometry

Protein expression patterns in tumor tissue and tumor microenvironment are analyzed by Imaging Mass Cytometry.

Sponsors & Collaborators

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • University of Zurich

    collaborator OTHER

  • University Hospital, Zürich

    collaborator OTHER

  • Andreas Wicki

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-11
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06680726 on ClinicalTrials.gov